Brain Tropia

Company Description

History

- March 2003. Establishment of Braintropia Co., Ltd.
- August 2000. Establishment of its Anyang Factory
- October 2000. Started producing BT-11.
- May 2002. Launched BT-11.
- September 2002. Launched its BT-11 capsule
- March 2003. Signed a Business Agreement with Dongwon F & B Co., Ltd.

Company Vision

- To develop a cerebrovascular medicine
- To develop an Alzheimer's disease medicine
- To develop a memory cure medicine
- Gene Line Therapy
- Resuscitation Accelerating Therapy for Brain Injury
- Pursuing mankind's happiness and improving quality of life through the development of vaccines


ManpoBrain Tropiar

- CEO's high level of domestic and international recognition and reliability in neurological circles and the public
- Rational organization composed of core research personnel in each field of Alzheimer's disease-related research

Technology

- To develop new medicines and accumulate know-how based on mechanisms at the outbreak of Alzheimer's disease
- To retain endothelial progenitor cell transplantation and gene line therapy
- 4 Patent Registrations, 2 Patent Applications


Management

- To build a stable management base with investments at the initial stage
- To establish a core base for basic researches by utilizing a large-scale research budget backed by the government
- To secure efficiency and flexibility through active outsourcing

Marketing

- To successfully enter the market at an early stage by forging business agreements with Ilyang Pharmaceuticals Co., Ltd. and other companies that have high name recognition
- To secure distribution channels through strategic business cooperation in development projects
- To conduct active promotion activities through the press, papers, seminars, and websites